Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthes-Stratec Finds Spine Solutions To Access Artificial Disc Market

This article was originally published in The Gray Sheet

Executive Summary

Synthes-Stratec's purchase of Spine Solutions provides access to a total artificial disc market projected to grow to $3 bil. by 2008
Advertisement

Related Content

Viscogliosi Bros. Spawns Small Bone/Joint Orthopedics Firm
Nonfusion Alternative To Artificial Discs Acquired By Abbott/Spinal Concepts
Lumbar Disc Developers Hold Their Own With Orthopedic Giants
Artificial Lumbar Disc Trial Results Could Make SpineCore Acquisition Target
Abbott Picks Spinal Concepts As Market Entry; InFix Device Approval Awaited
J&J/DePuy Projects SB Charite Artificial Lumbar Disc PMA Submission In 2004
Synthes-Stratec Anticipates Benefits From Centerpulse/S&N Combination
Spine Solutions Single-Level ProDisc Trial Enrollment To Wrap Up By Year-End
Medtronic’s $270 Mil. SDC Artificial Disc Purchase Supplements Internal R&D
Medtronic’s $270 Mil. SDC Artificial Disc Purchase Supplements Internal R&D
Advertisement
UsernamePublicRestriction

Register

MT017887

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel